patien

  1. T

    Phase 2 Clinical Trial Of Ibrutinib Shows High Overall Response, Remissions In Patien

    An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable results with few side effects. Researchers from The University of Texas MD Anderson Cancer Center presented interim findings of the multi-center Phase...
  2. T

    The Relevance Of SCIP Benchmarks Questioned Among Coronary Artery Bypass Graft Patien

    Cardiothoracic surgeons and endocrinologists from Boston Medical Center (BMC) have found that among patients undergoing coronary artery bypass graft (CABG) surgery, achieving Surgical Care Improvement Project (SCIP) benchmarks for glycemic control may be irrelevant when perioperative continuous...
  3. T

    Vicus Therapeutics Announces Initiation Of Phase 2 Trial To Evaluate VT-122 In Patien

    Vicus Therapeutics, LLC, announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma)...
  4. T

    Colorado Hospital Receives National Recognition For Outstanding Achievement In Patien

    The Leapfrog Group's annual class of top hospitals was announced in Washington, DC at Leapfrog's 10th anniversary meeting and named St. Anthony Summit Medical Center, a Centura Health hospital, in Frisco, Colorado. St. Anthony Summit Medical Center was selected as one of only five rural...
  5. T

    Surgeons Train On The First FDA-Approved Total Artificial Heart For Transplant Patien

    A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart's function while the patient waits for a heart transplant. Methodist will be the first hospital in...
Back
Top